Zacks Investment ResearchFri, 08 May 2026 16:11:09 GMTIOVA Q1 Earnings Match Estimates, Sales Miss, Stock Down 13%AMRN+0.47%
Zacks Investment ResearchTue, 05 May 2026 17:01:08 GMTAll You Need to Know About Amarin (AMRN) Rating Upgrade to Strong BuyAMRN+0.47%
Zacks Investment ResearchThu, 30 Apr 2026 18:05:26 GMTAmarin's Q1 Loss Narrower Than Expected, Sales Increase Y/YAMRN+0.47%
Seeking AlphaWed, 29 Apr 2026 20:42:01 GMTAmarin Corporation plc (AMRN) Q1 2026 Earnings Call TranscriptAMRN+0.47%
Zacks Investment ResearchThu, 23 Apr 2026 14:43:29 GMTHas Amarin (AMRN) Outpaced Other Medical Stocks This Year?AMRN+0.47%
The Motley FoolSat, 07 Mar 2026 06:15:00 GMTHere's Why I Wouldn't Touch Amarin With a 10‑Foot Pole Given Its Patent and Competition RisksAMRN+0.47%
Zacks Investment ResearchThu, 05 Mar 2026 14:25:42 GMTAMRN Stock Soars 37.7% in a Year: Here's What You Need to KnowAMRN+0.47%
Zacks Investment ResearchThu, 26 Feb 2026 15:25:18 GMTAmarin's Q4 Earnings Beat Estimates, Stock Down as Revenues MissAMRN+0.47%
Seeking AlphaWed, 25 Feb 2026 19:58:00 GMTAmarin Corporation plc (AMRN) Q4 2025 Earnings Call TranscriptAMRN+0.47%
